Oncolytics Biotech Inc.

Informe acción TSX:ONC

Capitalización de mercado: CA$125.6m

Oncolytics Biotech Dirección

Dirección controles de criterios 3/4

El CEO de Oncolytics Biotech es Wayne Pisano, nombrado en Jun 2024, tiene una permanencia de menos de un año. posee directamente un 0.25% de las acciones de la empresa, con un valor de CA$309.60K. La antigüedad media del equipo directivo y de la junta directiva es de 2.9 años y 5.5 años, respectivamente.

Información clave

Wayne Pisano

Chief Executive Officer (CEO)

CA$165.0k

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOless than a year
Participación del CEO0.2%
Permanencia media de la dirección2.9yrs
Promedio de permanencia en la Junta Directiva5.5yrs

Actualizaciones recientes de la dirección

Recent updates

We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Feb 23
We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?

Nov 10
Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?

We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Jul 07
We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?

Mar 24
Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?

Is Oncolytics Biotech (TSE:ONC) In A Good Position To Invest In Growth?

Dec 09
Is Oncolytics Biotech (TSE:ONC) In A Good Position To Invest In Growth?

We're Keeping An Eye On Oncolytics Biotech's (TSE:ONC) Cash Burn Rate

Aug 25
We're Keeping An Eye On Oncolytics Biotech's (TSE:ONC) Cash Burn Rate

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

May 12
Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth

Dec 02
We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth

We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth

Aug 05
We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth

Companies Like Oncolytics Biotech (TSE:ONC) Are In A Position To Invest In Growth

Apr 15
Companies Like Oncolytics Biotech (TSE:ONC) Are In A Position To Invest In Growth

We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Dec 31
We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

CEO

Wayne Pisano (69 yo)

less than a year

Permanencia

CA$165,010

Compensación

Mr. Wayne F. Pisano, MBA, is Interim Chief Executive Officer at Oncolytics Biotech Inc. since June 24, 2024. He has been an Independent Director of Altimmune, Inc. since August 30, 2018. Mr. Pisano had bee...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Wayne Pisano
Interim CEO & Chairman of the Boardless than a yearCA$165.01k0.25%
CA$ 309.6k
Kirk Look
Chief Financial Officer12yrsCA$1.32m1.16%
CA$ 1.5m
Matthew Coffey
Presidentless than a yearCA$2.25m0.12%
CA$ 157.0k
Thomas Heineman
Chief Medical Officer2.9yrsCA$1.36m0.67%
CA$ 841.4k
Allison Hagerman
Vice President of Product Development6.1yrsCA$727.64k0.67%
CA$ 842.3k
Amy Levin
Vice President of Clinical Operations1.8yrsCA$683.55ksin datos
Jon Patton
Director of Investor Relations & Communicationno datasin datossin datos
John Lievonen
Consultant5.5yrsCA$25.98ksin datos

2.9yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de ONC se considera experimentado (2.9 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Wayne Pisano
Interim CEO & Chairman of the Board11.5yrsCA$165.01k0.25%
CA$ 309.6k
Bernd Seizinger
Independent Director9.4yrsCA$123.96k0.49%
CA$ 619.6k
James Parsons
Independent Director2.4yrsCA$116.36ksin datos
Jonathan M. Rigby
Independent Director2.3yrsCA$107.40k0.41%
CA$ 513.2k
Patricia S. Andrews
Independent Directorless than a yearsin datossin datos
Angela Holtham
Independent Director10.4yrsCA$130.58k0.17%
CA$ 207.4k
Jean-Pierre Bizzari
Member of Scientific Advisory Boardno datasin datossin datos
Padmanee Sharma
Member of Scientific Advisory Boardno datasin datossin datos
Dirk Arnold
Member of Scientific Advisory Boardless than a yearsin datossin datos
Deborah Brown
Independent Director7yrsCA$124.95k0.064%
CA$ 79.8k
Martine Piccart
Member of Scientific Advisory Board7yrssin datossin datos
Richard Vile
Member of Scientific Advisory Board4.1yrssin datossin datos

5.5yrs

Permanencia media

68yo

Promedio de edad

Junta con experiencia: La junta directiva de ONC se considera experimentada (5.5 años de antigüedad promedio).